Vivimed Labs Ltd Share Price

Q: What is the share price of Vivimed Labs Ltd today?

Vivimed Labs Ltd share price as on 12 Jun 2026 is ₹6.1

Pharmaceuticals

NSE: VIVIMEDLAB Small Cap ISIN: INE526G01021

As on 13 June 2026 at 02:32 IST

₹6.10

+ 0.00

(0.00%)

Sell Buy

Over 1 Month

-8.96%

Over 6 Months

-77.07%

Over 1 Year

None%

Over 3 Years

8.93%

Vivimed Labs Ltd Summary

Close ₹6.10

Open ₹6.25

High ₹6.40

Low ₹6.01

Volume 1,32,139

Net Turnover (in Cr) ₹0.081

52Wk High ₹29.40

52Wk Low ₹5.15

52Wk High / Low

5.15

29.40

Vivimed Labs Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹50.58

EPS (TTM) -

Book Value (BV) 0.92

Div. Yield -

P/E (TTM) -1.48

Price/Book Value 6.62

Delivery % -

Face Value 2

Key Ratios

PE Ratio -

PB Ratio -

EV to Sales -

PEG Ratio -

ROA -5.75

ROE -

Debt-Equity 10.44

Net Profit Margin -30.41

Operating Profit Margin -9.97

Vivimed Labs Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	120.64	159.05	188.07	238.56	871.29
Total Expenses	152.49	204.87	518.72	303.39	941.15
Profit Before Tax	-31.85	-45.82	-330.65	-64.83	-69.86
Profit After Tax	-31.96	-45.45	-328.54	-67.65	-71.89
Operating Profit After Depreciation	-28.90	-43.39	-294.75	-25.07	-15.98

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	407.67	417.93	435.81	519.89	501.67
Total Non Current Assets	593.28	608.33	656.06	758.75	760.62
Total Current Assets	327.56	342.58	338.99	507.27	528.71
Total Assets	920.84	950.91	995.05	1,266.01	1,289.33
Total Shareholder's Fund	-35.17	-5.46	39.42	364.29	431.58

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	-1.75	-23.99	35.32	27.54	567.27
Net Cash Used In Investing Activities	-4.53	28.29	-4.96	-16.41	404
Net Cash Used In Financing Activities	4.96	-6.03	-33.78	-10.38	-1,015.33

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	107.79	146.37	177.06	219.63	216.12
Total Expenses	139.28	190.75	507.19	284.56	239.63
Profit Before Tax	-31.50	-44.38	-330.13	-64.94	-23.51
Profit After Tax	-31.50	-44.38	-328.01	-67.75	-23.28
Operating Profit After Depreciation	-28.96	-42.48	-294.85	-25.41	17.98

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	315.28	326.32	342.86	428.81	416.50
Total Non Current Assets	391.18	405.75	524.66	629.97	636.09
Total Current Assets	247.78	275.72	271.16	441.81	458.75
Total Assets	638.95	681.47	795.82	1,071.79	1,094.83
Total Shareholder's Fund	58.49	89.41	133.31	457.27	524.47

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	5.73	-96.52	32.87	25.31	179.52
Net Cash Used In Investing Activities	-4.06	99.83	-1.60	-11.34	-138.20
Net Cash Used In Financing Activities	-2.53	-5.51	-34.70	-13.21	-46.40

Particulars (in ₹ Cr.)	2025-12	2025-09	2025-06	2025-03	2024-12
Total Revenue	15.99	20.61	21.39	25.61	36.51
Total Expenses	26.91	21.57	21.67	28.08	35.45
Profit Before Tax	-16.55	-7.31	-5.49	-5.49	-5.97
Profit After Tax	-16.55	-7.30	-5.49	-5.60	-5.98
Operating Profit after Depreciation	-10.92	-0.75	0.10	1.75	1.13

Particulars (in ₹ Cr.)	2025-12	2025-09	2025-06	2025-03	2024-12
Total Revenue	11.63	18.66	17.94	22.58	34.23
Total Expenses	22.85	19.98	18.48	25.06	34.41
Profit Before Tax	-16.56	-7.44	-5.50	-4.42	-6.98
Profit After Tax	-16.57	-7.45	-5.50	-4.42	-6.97
Operating Profit after Depreciation	-11.22	-1.16	-0.18	1.67	-0.18

Vivimed Labs Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 5.94

S2 5.78

S3 5.55

Pivot 6.17

R1 6.33

R2 6.56

R3 6.72

Moving Average

20 SMA 6.43

50 SMA 6.62

100 SMA 7.03

200 SMA 8.83

Vivimed Labs Ltd Corporate Actions

No available data

AGM Date: 30 Sep 2021

Vivimed Labs Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 25 2021 to September 30 2021 (both days inclusive) for the purpose of Annual General Meeting (AGM) of the Company to be held on September 30 2021. 1. Further to our letter dated August 13, 2021 in relation to the scheduled date for the 33rd Annual General Meeting ('AGM') of the Company to be held on Thursday, September 30, 2021 through video conferencing ('VC') / other audio visual means ('OAVM'), we bring to your kind notice that due to unavoidable/administrative issues ,the Board of Directors of the Company, vide Circular Resolution dated 4th day of September, 2021 have decided to postpone the 33rd AGM of the Company Scheduled to be held on 30th day of September, 2021.The revised date for the 33rd AGM of the Company shall be decided in due course by the Board of Directors of the Company and same shall be informed to the Stock Exchanges. 2. The Board of Directors of the Company, vide Circular Resolution dated 4th day of September, 2021 have decided to make an application to the Registrar of Companies (ROC),Bangalore - seeking extension of time for holding Annual General Meeting (AGM) of the Company for FY 2020-21 (As Per BSE Announcement dated on 04.09.2021) A.G.M (Cancelled) (As Per BSE Bulletin dated on 09.09.2021)

AGM Date: 17 Feb 2023

AGM 17/02/2023 Notice of 33rd Annual General Meeting (AGM) and Book Closure for AGM. The Board of Directors of the Company at its meeting held on Friday, January 13, 2023 inter alia, have approved I resolved! taken note ofthe following: 1. Directors Report for the financial year ended 31.03.2021 together with annexure thereto. 2. Convening of Annual General Meeting (AGM) on 17.02.2023 and Notice of AGM. 3. Fixed Book closure dates from Monday, of February 13, 2023 to Friday, of February 17, 2023 (both days inclusive) for the purpose of AGM. The Board meeting concluded at 15.30 Hrs. Notice of 33rd Annual General Meeting (AGM), Annual Report for the financial year 2020-21 and Book Closure for AGM. (As Per BSE Announcement Dated on 13/01/2023) Proceedings of the 33rd Annual General Meeting (AGM) held on 17' February, 2023 (As Per BSE Announcement Dated on 17.02.2023) Pursuant to Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the voting results of the 33rd Annual General Meeting of the Company held on 17th February, 2023 and the Scrutinizer Report. (As per BSE Announcement Dated on 20/02/2023)

AGM Date: 27 Mar 2023

The Board of Directors of the Company at its meeting held on February 13, 2023 inter alia, have approved / resolved/ taken note of the following: 1. Considered and approved the submission of the Un-audited Financial Results (Standalone & Consolidated) for the Quarter and nine months ended December 31, 2022 attached herewith; 2. Auditors's Limited Review Report on the Un-audited Financial Statements of the Company for the Quarter and nine months ended December 31, 2022. 3. Directors Report for the financial year ended 31.03.2022 together with annexure thereto. 4. Convening of Annual General Meeting (AGM) on 18.03.2023 and Notice of AGM. 5. Fixed Book closure dates from Monday, March 13, 2023 to Saturday, March 18, 2023 (both days inclusive) for the purpose of AGM. The Board Meeting concluded at 6.00 P.M. With reference to the above, the following changes/ corrections are for your information: 1. Convening of 34th Annual General Meeting (AGM) for the financial year 2022 on 27.03.2023. 2. Fixed Book closure dates from Wednesday, March 22, 2023 to Monday, March 27, 2023 (both days inclusive) for the purpose of 34th AGM. You are requested to take note of the above. (As Per BSE Announcement dated on 15.02.2023) Notice of 34th Annual General Meeting (AGM), Annual Report for the financial year 2021-22 and Book Closure for AGM. (As Per BSE Announcement Dated on 02/03/2023) AGM 27/03/2023 (As Per BSE Bulletin Dated on 03.03.2023) Proceedings of the 34th Annual General Meeting (AGM) held on 27th March, 2023 Disclosure of Voting Results of the 34th Annual General Meeting held on 27th March, 2023 (As Per BSE Announcement Dated on 27/03/2023)

AGM Date: 13 Nov 2023

The Board of Directors of the Company at its meeting held on October 18, 2023 inter alia, have approved / resolved/ taken note of the following: 1. Directors Report for the financial year ended 31.03.2023 together with annexure thereto. 2. Convening of Annual General Meeting (AGM) on 13.11.2023 and Notice of AGM. 3. Fixed Book closure dates from Wednesday, of November 08, 2023 to Monday, of November 13, 2023 (both days inclusive) for the purpose of AGM. Annual Report FY2023 AGM on November 13,2023 Book Closure: November 8, 2023 to November 13, 2023 (As Per BSE Announcement Dated on 20/10/2023) Proceedings of the 35th Annual General Meeting. (As per BSE Announcement Dated on 14/11/2023) Annual General Meeting Results (As Per BSE Announcement Dated on 15.11.2023) Revised Proceedings of the 35th Annual General Meeting (AGM)-Conclusion time of the AGM (As Per BSE Announcement Dated on 28/12/2023)

AGM Date: 03 Jan 2025

AGM 03/01/2025 Annual Report FY2024 (As per BSE Announcement Dated on 11/12/2024) Attached (As per BSE Announcement Dated on 03/01/2025) Attached Voting Results & Scrutinizer Report (As Per BSE Announcement Dated on: 04/01/2025)

AGM Date: 30 Sep 2025

AGM Notice. AGM Proceedings (As Per BSE Announcement Dated on:01.10.2025) AGM Voting Results (As per BSE Announcement dated on: 01/10/2025) Revised AGM Proceedings (As Per BSE Announcement Dated on: 07/10/2025)

Vivimed Labs Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,794.30	₹4,30,512.67
Divis Laboratories Ltd	₹6,651.25	₹1,76,569.79
Torrent Pharmaceuticals Ltd	₹4,570	₹1,54,669.57
Cipla Ltd	₹1,383	₹1,11,725.01
Zydus Lifesciences Ltd	₹1,105.65	₹1,11,254.26

Vivimed Labs Ltd Top Mutal Funds Invested

No data available

Vivimed Labs Ltd News

Vivimed Labs to convene board meeting

On 28 May 2026

18 May 2026, 11:07 am

Vivimed Labs to table results

On 13 March 2026

10 Mar 2026, 09:42 am

Vivimed Labs revises board meeting date

To a later date

12 Feb 2026, 11:45 am

Vivimed Labs to convene board meeting

On 13 February 2026

03 Feb 2026, 10:16 am

Vivimed Labs to conduct EGM

On 10 December 2025

19 Nov 2025, 09:27 am

Vivimed Labs Ltd Stock Analysis

Annual revenue for Vivimed Labs Ltd decreased by 26.36% to ₹107.79 crore in FY 2025 from ₹146.37 crore in FY 2024.
Annual Net Profit for Vivimed Labs Ltd decreased by 29.03% to ₹-31.50 crore in FY 2025 from ₹-44.38 crore in FY 2024.
Promoter Shareholding in Vivimed Labs Ltd decreased by 2.51% in the most recent quarter, from 7.77% in December 2025 to 7.57% in March 2026.
Vivimed Labs Ltd delivered a 1-year return of 0% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
Vivimed Labs Ltd share price moved remains unchanged by 0.00% from its previous close of INR ₹6.10. The latest Vivimed Labs Ltd share price is INR ₹6.10.
Vivimed Labs Ltd share price today has been at a low of 6.10 and a high of 6.29. Over the past 52 weeks, the Vivimed Labs Ltd share price has seen a low of 5.15 and a high of 29.40.